ALHC vs. PHR, PRVA, HCSG, CYRX, MGLN, OSCR, TRUP, CLOV, NEUE, and BHG
Should you be buying Alignment Healthcare stock or one of its competitors? The main competitors of Alignment Healthcare include Phreesia (PHR), Privia Health Group (PRVA), Healthcare Services Group (HCSG), Cryoport (CYRX), Magellan Health (MGLN), Oscar Health (OSCR), Trupanion (TRUP), Clover Health Investments (CLOV), NeueHealth (NEUE), and Bright Health Group (BHG).
Alignment Healthcare (NASDAQ:ALHC) and Phreesia (NYSE:PHR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.
In the previous week, Alignment Healthcare and Alignment Healthcare both had 18 articles in the media. Alignment Healthcare's average media sentiment score of 1.09 beat Phreesia's score of 0.35 indicating that Alignment Healthcare is being referred to more favorably in the media.
Alignment Healthcare has a net margin of -7.81% compared to Phreesia's net margin of -31.87%. Phreesia's return on equity of -46.81% beat Alignment Healthcare's return on equity.
Phreesia received 79 more outperform votes than Alignment Healthcare when rated by MarketBeat users. Likewise, 65.46% of users gave Phreesia an outperform vote while only 62.34% of users gave Alignment Healthcare an outperform vote.
Phreesia has lower revenue, but higher earnings than Alignment Healthcare. Alignment Healthcare is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.
Alignment Healthcare currently has a consensus price target of $9.20, suggesting a potential upside of 16.75%. Phreesia has a consensus price target of $31.38, suggesting a potential upside of 65.88%. Given Phreesia's stronger consensus rating and higher probable upside, analysts plainly believe Phreesia is more favorable than Alignment Healthcare.
86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 6.6% of Alignment Healthcare shares are held by company insiders. Comparatively, 5.8% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Alignment Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Phreesia has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500.
Summary
Phreesia beats Alignment Healthcare on 10 of the 18 factors compared between the two stocks.
Get Alignment Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alignment Healthcare Competitors List
Related Companies and Tools
